4//SEC Filing
Elsbernd Brian 4
Accession 0001161697-25-000445
CIK 0001369568other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:00 PM ET
Size
9.2 KB
Accession
0001161697-25-000445
Insider Transaction Report
Form 4
Elsbernd Brian
Chief Compliance/Legal Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2025-12-08+7,067→ 241,237 total - Tax Payment
Common Stock, par value $0.001 per share
2025-12-08−2,780→ 238,457 total - Exercise/Conversion
Restricted Stock Units
2025-12-08−7,067→ 962,809 total→ Common Stock (7,067 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
- [F3]Derivative securities vest in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025, and 1/3rd on December 8, 2026.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 8, 2025.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001763511
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:00 PM ET
- Size
- 9.2 KB